This report studies the
Global Overactive Bladder Drug Market, analyzes and researches the Overactive Bladder Drug development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Astellas Pharma, Inc. (Japan)
Pfizer, Inc. (U.S.)
Teva Pharmaceutical Industries Limited (Israel)
Allergan, Plc (Ireland)
Medtronic plc (Ireland)
Mylan N.V. (U.S.)
Endo International plc (Ireland)
Hisamitsu Pharmaceutical Co., Inc. (Japan)
Sanofi (France)
Apotex, Inc. (Canada)
Cogentix Medical, Inc. (U.S.)
Aurobindo Pharma Limited (India)
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, the product can be split into
Anticholinergics
Solifenacin
Oxybutynin
Darifenacin
Fesoterodine
Tolterodine
Trospium
Others
Market segment by Application, Overactive Bladder Drug can be split into
Idiopathic Bladder Overactivity
Neurogenic Bladder Overactivity
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Overactive Bladder Drug Market Size, Status and Forecast 2022
1 Industry Overview of Overactive Bladder Drug
1.1 Overactive Bladder Drug Market Overview
1.1.1 Overactive Bladder Drug Product Scope
1.1.2 Market Status and Outlook
1.2 Global Overactive Bladder Drug Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Overactive Bladder Drug Market by Type
1.3.1 Anticholinergics
1.3.2 Solifenacin
1.3.3 Oxybutynin
1.3.4 Darifenacin
1.3.5 Fesoterodine
1.3.6 Tolterodine
1.3.7 Trospium
1.3.8 Others
1.4 Overactive Bladder Drug Market by End Users/Application
1.4.1 Idiopathic Bladder Overactivity
1.4.2 Neurogenic Bladder Overactivity
2 Global Overactive Bladder Drug Competition Analysis by Players
2.1 Overactive Bladder Drug Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Astellas Pharma, Inc. (Japan)
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Overactive Bladder Drug Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Pfizer, Inc. (U.S.)
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Overactive Bladder Drug Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Teva Pharmaceutical Industries Limited (Israel)
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Overactive Bladder Drug Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Allergan, Plc (Ireland)
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Overactive Bladder Drug Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Medtronic plc (Ireland)
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Overactive Bladder Drug Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Mylan N.V. (U.S.)
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Overactive Bladder Drug Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Endo International plc (Ireland)
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Overactive Bladder Drug Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Hisamitsu Pharmaceutical Co., Inc. (Japan)
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Overactive Bladder Drug Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Sanofi (France)
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Overactive Bladder Drug Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Apotex, Inc. (Canada)
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Overactive Bladder Drug Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Cogentix Medical, Inc. (U.S.)
3.12 Aurobindo Pharma Limited (India)
4 Global Overactive Bladder Drug Market Size by Type and Application (2012-2017)
4.1 Global Overactive Bladder Drug Market Size by Type (2012-2017)
4.2 Global Overactive Bladder Drug Market Size by Application (2012-2017)
4.3 Potential Application of Overactive Bladder Drug in Future
4.4 Top Consumer/End Users of Overactive Bladder Drug
5 United States Overactive Bladder Drug Development Status and Outlook
5.1 United States Overactive Bladder Drug Market Size (2012-2017)
5.2 United States Overactive Bladder Drug Market Size and Market Share by Players (2016 and 2017)
6 EU Overactive Bladder Drug Development Status and Outlook
6.1 EU Overactive Bladder Drug Market Size (2012-2017)
6.2 EU Overactive Bladder Drug Market Size and Market Share by Players (2016 and 2017)
7 Japan Overactive Bladder Drug Development Status and Outlook
7.1 Japan Overactive Bladder Drug Market Size (2012-2017)
7.2 Japan Overactive Bladder Drug Market Size and Market Share by Players (2016 and 2017)
8 China Overactive Bladder Drug Development Status and Outlook
8.1 China Overactive Bladder Drug Market Size (2012-2017)
8.2 China Overactive Bladder Drug Market Size and Market Share by Players (2016 and 2017)
9 India Overactive Bladder Drug Development Status and Outlook
9.1 India Overactive Bladder Drug Market Size (2012-2017)
9.2 India Overactive Bladder Drug Market Size and Market Share by Players (2016 and 2017)
10 Southeast Asia Overactive Bladder Drug Development Status and Outlook
10.1 Southeast Asia Overactive Bladder Drug Market Size (2012-2017)
10.2 Southeast Asia Overactive Bladder Drug Market Size and Market Share by Players (2016 and 2017)
11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Overactive Bladder Drug Market Size (Value) by Regions (2017-2022)
11.1.1 United States Overactive Bladder Drug Revenue and Growth Rate (2017-2022)
11.1.2 EU Overactive Bladder Drug Revenue and Growth Rate (2017-2022)
11.1.3 Japan Overactive Bladder Drug Revenue and Growth Rate (2017-2022)
11.1.4 China Overactive Bladder Drug Revenue and Growth Rate (2017-2022)
11.1.5 India Overactive Bladder Drug Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Overactive Bladder Drug Revenue and Growth Rate (2017-2022)
11.2 Global Overactive Bladder Drug Market Size (Value) by Type (2017-2022)
11.3 Global Overactive Bladder Drug Market Size by Application (2017-2022)
12 Overactive Bladder Drug Market Dynamics
12.1 Overactive Bladder Drug Market Opportunities
12.2 Overactive Bladder Drug Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Overactive Bladder Drug Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Overactive Bladder Drug Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
About Us
Global QYResearch is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.
Contact Us:
Unit 1, 26 Cleveland Road, South Woodford, London,
E182AN, United Kingdom
Call: +44 20 3239 2407
Comments
Post a Comment